Diana Lindén

KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma

Abdlsattar Zebary, Katarina Omholt, Ismini Vassilaki et al. · Journal of Dermatological Science · 2013 · 93 citations

Medicine, Acral Lentiginous Melanoma, Melanoma +5

MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma

Rainer Tuominen, Rosalyn Jewell, Joost J. van den Oord et al. · International Journal of Cancer · 2014 · 52 citations · Full text

Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma

C. Christian Johansson, Suzanne Egyházi, Giuseppe Masucci et al. · Cancer Immunology Immunotherapy · 2008 · 49 citations · Full text

Skin Cancer, Medicine, Melanoma +9

Lack of Cytoplasmic ERK Activation Is an Independent Adverse Prognostic Factor in Primary Cutaneous Melanoma

Braslav Jovanovic, Doris Kröckel, Diana Lindén et al. · Journal of Investigative Dermatology · 2008 · 43 citations

Tumor Biology, Medicine, Cutaneous Biology +9

<i>MC1R</i> variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters

Veronica Höiom, Rainer Tuominen, Max Käller et al. · Pigment Cell & Melanoma Research · 2008 · 43 citations